Class # | Subject | Catalog # | Section | Title | Enrollment Cap | Wait List | Currently Enrolled | Seats Available |
---|---|---|---|---|---|---|---|---|
9841 | PH TX | 270 | 001 | Common Medicines | 15 | 0 | 1 | 14 |
3268 | PH TX | 2700 | 001 | Common Medicines | 100 | 0 | 55 | 45 |
3192 | PH TX | 5121 | 001 | Biomedical Basis Dis | 62 | 0 | 62 | 0 |
3193 | PH TX | 5221 | 001 | Pharmacology II | 65 | 0 | 57 | 8 |
3269 | PH TX | 5990 | 001 | Special Problems | 50 | 0 | 0 | 50 |
3194 | PH TX | 6221 | 001 | Pharmacology II | 20 | 0 | 2 | 18 |
4459 | PH TX | 6680 | 001 | Statistical Methods | 10 | 0 | 17 | -7 |
3797 | PH TX | 6710 | 001 | Dev Biochem Tox | 25 | 0 | 2 | 23 |
11483 | PH TX | 6970 | 001 | Thesis Research-MS | 1 | 0 | 0 | 1 |
17668 | PH TX | 6970 | 002 | Thesis Research-MS | 1 | 0 | 1 | 0 |
6160 | PH TX | 7114 | 001 | Prin Tox | 20 | 0 | 6 | 14 |
10754 | PH TX | 7270 | 001 | Neuropharmacology | 50 | 0 | 5 | 45 |
15251 | PH TX | 7500 | 001 | Biochemical Mechanisms | 10 | 0 | 6 | 4 |
12527 | PH TX | 7620 | 001 | Analytical Tox | 10 | 0 | 0 | 10 |
10755 | PH TX | 7710 | 001 | Pharm Res Exp I | 25 | 0 | 0 | 25 |
10756 | PH TX | 7720 | 001 | Pharm Res Exp II | 25 | 0 | 0 | 25 |
3270 | PH TX | 7890 | 001 | Research Seminar | 25 | 0 | 5 | 20 |
5503 | PH TX | 7920 | 001 | Research Pharmacology | 5 | 0 | 0 | 5 |
6331 | PH TX | 7920 | 026 | Research Pharmacology | 5 | 0 | 0 | 5 |
6332 | PH TX | 7920 | 028 | Research Pharmacology | 5 | 0 | 0 | 5 |
6333 | PH TX | 7920 | 029 | Research Pharmacology | 5 | 0 | 0 | 5 |
6334 | PH TX | 7920 | 031 | Research Pharmacology | 5 | 0 | 0 | 5 |
3271 | PH TX | 7970 | 001 | Thesis Research-PhD | 25 | 0 | 1 | 24 |
6335 | PH TX | 7970 | 024 | Thesis Research-PhD | 5 | 0 | 0 | 5 |
6336 | PH TX | 7970 | 027 | Thesis Research-PhD | 5 | 0 | 0 | 5 |
6337 | PH TX | 7970 | 028 | Thesis Research-PhD | 5 | 0 | 1 | 4 |
6338 | PH TX | 7970 | 029 | Thesis Research-PhD | 5 | 0 | 0 | 5 |
3272 | PH TX | 7980 | 001 | Faculty Consult-PhD | 25 | 0 | 0 | 25 |
3273 | PH TX | 7990 | 001 | Cont Reg PhD | 25 | 0 | 0 | 25 |